NYSE: ZTS
Zoetis Inc.
Healthcare · Drug Manufacturers - General
Market Cap
$33.00B
52w High
$161.77
52w Low
$72.38
P/E
12.58
Volume
8.56M
Outstanding Shares
419.23M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 49.24% over the last year. Revenue grew 2.4% over the trailing twelve months. Operating margin moved from 37.01% to 37.57%. Free cash flow declined 6.36% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 37.57%. A decisive move in revenue — currently up 2.4% — would be the clearest signal to resolve the ambiguity.
Company profile
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
15
Buy
15
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2026
Q3 FY26 · EPS est $1.85 · Revenue est $2.5B
View
Dividends
$2.09/shareQuarterlyDividend Achiever · 12yrSafeZTS pays a dividend with a 2.66% declared yield, 12 consecutive years of growth, growing at 17.08% annually, covered 2.6× by free cash flow.
Declared Yield
2.66%
Annual Div / Share
$2.09
5yr CAGR
+17.08%
Doubles every ~4.4yr
Payout Ratio
33.64%
Safe
Dividend Growth Rate
3yr CAGR
+12.96%
5yr CAGR
+17.08%
10yr CAGR
+18.97%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$2/mo
In 5 yrs
$4/mo
In 10 yrs
$7/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$27/yr $2/mo | $47/yr+76% $4/mo | $82/yr+211% $7/mo |
Long-range projections use a capped 12% annual growth assumption.
Yield-on-cost grows from 2.66% → 8.25% over 10yr
Analysis
Dividend Strengths
Dividend Achiever
ZTS has raised its dividend for 12 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 2.6× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 17.08% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
No strong risk signal stands out from the latest period pair.